Medley (4480.T) Stock Price

Medley Price

JPX·CLOSED
2,430.00
​
Market closed

Revenue has compounded at 46.7% per year over the past 8 years to 36.79 B JPY. Earnings per share have grown at 49.2% per year over the last 8 years. Medley's net margin stands at 2.7%, down from 5.2% several years earlier. Analysts set a median price target of 3,417.00 JPY, implying 40.6% above the current price. Of 10 analysts, 7 rate the stock a buy — an overall Buy consensus.

Medley stock price

Access this data via the Eulerpool API

Medley business model & stock analysis

Medley Inc is a global company specializing in the production and sale of pharmaceutical products. The company was founded in 1985 as a small business and has since become a leading player in the pharmaceutical industry, operating in over 150 countries. Medley Inc produces a variety of products in different areas such as cardiology, gastroenterology, oncology, orthopedics, neurology, and dermatology. The company's business model is based on the development and sale of generic products, which are imitation products of patented drugs. Medley Inc focuses on producing high-quality and effective medicines at competitive prices. The company has production sites in various countries to meet the demand for drugs in each region. In addition to being a manufacturer of medicines, Medley Inc also offers services such as drug distribution, clinical studies, research and development, consulting for pharmaceutical manufacturers, and customer training. The company places great importance on the quality and safety of its products and services and has implemented a comprehensive quality management system to meet its high standards. The product range of Medley Inc includes a variety of drugs used in different indications, including well-known drugs such as Tamoxifen for cancer, Fluoxetine for depression, Oxycodone for pain relief, and Levofloxacin as an antibiotic. Medley Inc strives to make affordable medications accessible to all people and works to improve healthcare worldwide. The company has formed long-term partnerships with organizations and governments in emerging countries to enhance access to affordable medicines. Overall, Medley Inc is a significant player in the pharmaceutical industry, focusing on the production of generics and improving healthcare globally. Through its efforts in quality, innovation, and partnerships, the company aims to have a positive impact on society.

Frequently asked questions about Medley

The main competitors of Medley Inc in the market include Blackstone Group, Ares Management Corporation, and Apollo Global Management.

The business model of Medley Inc is focused on providing investment management services. As an investment firm, Medley Inc specializes in credit strategies, including direct lending, corporate credit, and alternative credit. Medley Inc aims to generate attractive risk-adjusted returns for its investors by offering customized financing solutions to middle-market companies. By leveraging its industry expertise and network, Medley Inc identifies investment opportunities and actively manages its funds to optimize returns. The company's business model centers around delivering value to its clients and shareholders through a disciplined investment approach and a commitment to generating consistent, long-term growth.

Medley Inc is primarily active in the financial services industry.

Medley Inc is a renowned company with a rich history and impressive background in the financial industry. Established in [year], Medley Inc has grown to become a leading player in providing financial and investment services to a diverse clientele. With its extensive expertise and experience, Medley Inc has built a strong reputation for delivering innovative solutions and achieving exceptional results. The company's commitment to excellence, combined with its client-centric approach, has earned Medley Inc a loyal customer base and positioned it as a trusted partner for individuals and businesses seeking reliable financial guidance and support. Through its comprehensive range of services and esteemed track record, Medley Inc continues to thrive and shape the financial landscape.

Medley Inc, a reputable company in the stock market, has achieved numerous significant milestones throughout its history. Over the years, Medley Inc has successfully expanded its presence in the industry, launching innovative products and services, enhancing shareholder value, and attracting a large customer base. The company's commitment to excellence and consistent growth has led to noteworthy achievements, such as significant revenue growth, strategic acquisitions, successful partnerships, and global recognition. Medley Inc's dedication to meeting investor expectations, delivering exceptional performance, and fostering financial success makes it a standout player in the stock market industry.

Medley Inc primarily operates in the United States. As a leading financial services company, Medley Inc focuses on providing investment solutions and strategic advice to its clients across various industries in the US market. With a comprehensive understanding of the domestic market landscape, Medley Inc leverages its expertise to deliver tailored financial solutions and drive growth for its clients.

Medley Inc represents strong values and a clear corporate philosophy. The company prioritizes integrity, innovation, and exceptional client service. With a commitment to transparency and ethical practices, Medley strives to build long-term relationships with its clients based on trust. Their corporate philosophy emphasizes teamwork and collaboration, enabling them to provide customized solutions tailored to each client's unique needs. Medley Inc's dedication to excellence, professionalism, and strategic thinking allows them to consistently deliver superior value and results.

Analysts currently set an average price target of 3,400.00 JPY for the Medley stock (median: 3,417.00 JPY), implying +39.9 % versus the latest price. The consensus is based on 10 analyst ratings.

10 analysts currently rate the Medley stock: 7 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Medley to generate revenue of 46.28 B JPY and earnings per share of 78.24 JPY.

Converted at the current exchange rate, the Medley share trades at 13.70 EUR (2,430.00 JPY).

The Medley share (4480.T) is listed on 3 stock exchanges, including: Tokio (JPX) (4480.T), Frankfurt (3YV.F), München (3YV.MU).

Medley Inc. is a significant company specializing in providing innovative solutions in the healthcare and medical technology industry. The company's business model is focused on providing a variety of products and services to its customers to help improve their health and well-being. One of Medley Inc.'s key areas of focus is pharmaceuticals and biotechnology. The company has developed a wide range of products aimed at treating various health issues, including medications for cancer, cardiovascular diseases, diabetes, psychiatry and neurology problems, as well as infectious diseases. Another important area for Medley Inc. is medical technology. The company has developed a broad range of innovative medical devices to enable fast and accurate diagnosis and treatment of illnesses. This includes imaging devices, diagnostic and monitoring solutions, as well as innovative surgical devices and instruments. Additionally, Medley Inc. offers a wide range of healthcare services aimed at improving the health and well-being of its customers. These services include prevention and screening programs, coaching and counseling services, as well as treatment centers. In addition to these main areas, Medley Inc. also offers a variety of other services and products aimed at improving the health and well-being of its customers. These include products for prenatal care, childcare, assistive devices, and rehabilitation after injuries. The company generates its revenue primarily through the sale of its products and services. Medley Inc. has an extensive distribution infrastructure to successfully distribute its products and services. Moreover, the company regularly invests in research and development to improve its products and services and develop new ones. Medley Inc.'s business model is based on providing innovative and high-quality products and services to offer its customers better health and improved well-being. The company aims to continue investing in research and development to expand its product range and provide the best possible care to its customers. Answer: Medley Inc. is a company that provides innovative solutions in the healthcare and medical technology sector. It focuses on pharmaceuticals, biotechnology, medical technology, and healthcare services. The company generates revenue through product and service sales and invests in research and development. Its goal is to improve the health and well-being of its customers.

The expected revenue of Medley is 46.28 B JPY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Medley is 2.65 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Medley is currently 31.06. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medley stock.

The price-to-sales ratio (P/S) of Medley is currently 1.78. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medley stock.

The Eulerpool Quality Score for Medley is 4/10.

The ISIN of Medley is JP3921310003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Medley is A2PYB2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Medley is 4480.T. The ticker symbol is used to trade Medley shares on the stock exchange.

Fair ValueTerminal
2,381.40 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
97.06 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website medley.jp
Country
Currency
JPY
Initial public offering
Dec 12, 2019
ISIN
JP3921310003
Cusip
J41576109
Sedol
BK93ZN7
Market capitalization
77.76 B JPYLarge Cap
52-Week Range
PEG
4.03
P/E ratio
P/Ee 2026
29.30
P/Ee 2027
19.44
P/Ee 2028
14.10
P/Ee 2029
14.32
P/Ee 2030
11.31
P/S
P/Se
1.78
EV/EBIT
33.33
P/B Ratio
5.25
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.16 %
Last updated Oct 10, 2026, 7:04 AM

Medley Ticker

FRANKFURT · 3YV.FJPX · 4480.TMUNICH · 3YV.MU

Medley FIGI

4480:JP · BBG00MFDBFF44480:JT · BBG00QT98NN74480:JJ · BBG00QT98NY54480:JE · BBG00QT98P164480:JI · BBG00QT98P254480:JU · BBG00QT98P344480:JW · BBG00QT98P433YV:GR · BBG00X0SS3K63YV:GF · BBG00X0SS3L53YV:GM · BBG00X0SS3Q03YV:GZ · BBG00X0SVX264480EUR:EP · BBG00X0SXH74

All fundamentals and in-depth analysis of Medley

Our stock analysis for Medley stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medley. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.